Serena Group

SerenaGroup is a Boston-based, privately-held CRO and clinical trial site network founded in 2018 by Dr. Thomas Serena. The company has carved a distinct niche in the wound care sector, offering end-to-end clinical trial services supported by an extensive network of sites and deep therapeutic expertise. It generates revenue by partnering with biopharma and medtech sponsors to design and execute studies, primarily for advanced wound care products, helping them navigate regulatory and reimbursement challenges. The company's value proposition is built on transparency, physician involvement, and a data-driven approach to accelerate the development of new therapies.

Integrated clinical research organization (CRO) and site network platform specializing in wound care trials, featuring physician-driven protocol design, a proprietary site network for rapid enrollment, and advanced data analytics tailored for wound measurement and outcomes.

SerenaGroup competes in the niche wound care segment of the broader CRO market. It differentiates itself through deep therapeutic expertise, a physician-founded approach, and an integrated site network, competing against large, diversified CROs (like IQVIA, PPD) that have wound care divisions and other specialized, smaller research organizations.